Sanofi

Trend Analysis of Sanofi

Momentum is moderately positive, but not yet fully convincing, reflecting a gradual return of confidence rather than a clear acceleration. Recent news about the strengthening of the immunology pipeline is strategically encouraging, as it supports the case for an improvement in the medium-term growth profile, but the stock still needs to confirm this trend with more visible clinical and commercial results.